An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months

NCT00792103 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
198
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

NuPathe Inc.